Lingual alveolar soft part sarcoma responsive to pazopanib: A case report

RATIONALE: The multi-targeted tyrosine kinase inhibitors such as cediranib, sunitinib and pazopanib have been reported to be effective for alveolar soft part sarcoma (ASPS). The efficacy of pazopanib for the patient with lingual ASPS has yet to be reported. PATIENT CONCERNS: A 23-year old man presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshihiro, Tomoyasu, Tsuchihashi, Kenji, Nio, Kenta, Arita, Shuji, Nakano, Takafumi, Yasumatsu, Ryuji, Jiroumaru, Rina, Ariyama, Hiroshi, Kusaba, Hitoshi, Oda, Yoshinao, Akashi, Koichi, Baba, Eishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682820/
https://www.ncbi.nlm.nih.gov/pubmed/29095301
http://dx.doi.org/10.1097/MD.0000000000008470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682820/
https://www.ncbi.nlm.nih.gov/pubmed/29095301
http://dx.doi.org/10.1097/MD.0000000000008470

Ejemplares similares